Vista Pharmaceuticals enters into joint venture partnership with Pleiades Therapeutics

03 Feb 2026 Evaluate

Vista Pharmaceuticals has entered into a joint venture partnership with Pleiades Therapeutics to collaboratively pursue the end-to-end development of Generic Drug Products and Specialty Pharmaceutical Products for regulated as well as rest-of-the-world (ROW) markets.

This strategic partnership aims to synergize the R&D expertise of Pleiades Therapeutics with the robust manufacturing and established marketing presence of Vista Pharmaceuticals in the United States and other key pharmaceutical markets. The collaboration is expected to enhance operational capabilities, expand market reach, and strengthen the competitive positioning of both companies in the global pharmaceutical industry.

Vista Pharmaceuticals is engaged in manufacturing and selling of Pharmaceutical, medical and veterinary preparations. It offers over the counter & prescription generic drug products consisting of tablets, capsules and liquids covering various therapeutic categories.

Vista Pharma Share Price

7.50 0.12 (1.63%)
20-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.45
Dr. Reddys Lab 1298.95
Cipla 1255.85
Zydus Lifesciences 890.60
Lupin 2322.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×